Journal of Ophthalmology / 2020 / Article / Fig 2

Research Article

Effectiveness of Intravitreal Ranibizumab in Nonvitrectomized and Vitrectomized Eyes with Diabetic Macular Edema: A Two-Year Retrospective Analysis

Figure 2

Changes in the mean visual acuity (in logMAR) of the study groups during 24 months of follow-up. BCVA indicates best-corrected visual acuity. Post hoc tests using the Bonferroni correction revealed that IVR treatment elicited a significant improvement in BCVA values from baseline to 6th month of treatment (0.51 ± 0.26 vs. 0.39 ± 0.26, ) in the nonvitrectomized group.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.